8
Oct
2024
Chongqing Zhifei Biological Products Co.
Exhibitor at CPHI Milan 2024 stand 10G64, Finished Dosage Formulations
About Us
Categories
-
CN
-
2015On CPHI since
-
5000+Employees
Company types
Event information
CPHI Milan 2024
-
08 Oct 2024 - 10 Oct 2024
-
Fiera Milano, Italy
-
Visit us at stand 10G64, Finished Dosage Formulations
Products Featured at CPHI Milan 2024
-
Product Recombinant COVID-19 Vaccine(CHO Cell)
Zifivax is the first approved Recombinant COVID vaccine, there are more than 300million doses used worldwide. -
Product Recombinant Mycobacterium Tuberculosis Fusion Protein
C-TST is a new diagnose method to detect Mtb infectionfor,which uses antigen-specific (ESAT6 & CFP10) immune response, same with the principle of action used in IGRAs.(1)Suitable for Large Scale LTBI Screening;
(2)Non Cross-React with BCG Vaccine;
(3)WHO Guideline Recommended; q... -
Product semaglutide
we can supply the semaglutide API with a good price and good quality,we are also open for the cooperation model. -
Product Meningococcal Polysaccharide Vaccine
Chongqing zhifei biological products co., ltd offers a wide range of products which includes meningococcal polysaccharide vaccine. Function and use: it can be used to prevent epidemic cerebrospinal meningitis caused by meningococcus group a, c, y, and w135 infection. Contact us for more information. -
Product Group A, C Meningococcal Polysaccharide-Conjugate Vaccine
MeningACon is the first approved product in China,more than 36 million doses has been used.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance